Principia Biopharma

YTD

ALL

Why Robinhood?

You can watch PRNB and buy or sell other stocks, options, and ETFs commission-free!

About PRNB

Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.

CEO

Martin Babler

CEOMartin Babler

Employees

—

Employees—

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2008

Founded2008

Employees

—

Employees—

PRNB Key Statistics

Market cap

3.32B

Market cap3.32B

Price-Earnings ratio

-41.60

Price-Earnings ratio-41.60

Dividend yield

—

Dividend yield—

Average volume

793.58K

Average volume793.58K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$101.89

52 Week high$101.89

52 Week low

$25.35

52 Week low$25.35